Cargando…
Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy
Bullous pemphigoid (BP) is an autoimmune disease that mainly occurs in the elderly, severely affecting their health and life quality. Traditional therapy for BP is mainly based on the systemic use of corticosteroids, but long-term use of corticosteroids results in a series of side effects. Type 2 in...
Autores principales: | Zhang, Luyao, Chen, Zihua, Wang, Lanting, Luo, Xiaoqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978795/ https://www.ncbi.nlm.nih.gov/pubmed/36875098 http://dx.doi.org/10.3389/fimmu.2023.1115083 |
Ejemplares similares
-
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms
por: Cole, Connor, et al.
Publicado: (2022) -
New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019) -
The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2019) -
Adaptive and innate immune pathogenesis of bullous pemphigoid: A review
por: Yan, Tianmeng, et al.
Publicado: (2023) -
Biological treatment for bullous pemphigoid
por: Oren-Shabtai, Meital, et al.
Publicado: (2023)